Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoram Reiter

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Cancer Research|April 3, 2004
Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cellsSangKon Oh, Masaki Terabe, C David Pendleton, et al.
Molecular Systems Biology|April 30, 2009
Predicting and controlling the reactivity of immune cell populations against cancerKfir Oved, Eran Eden, Martin Akerman, et al.
Journal of Autoimmunity|October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell toleranceArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
European Journal of Immunology|September 16, 2004
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragmentsGerhard Held, Mitsutoshi Matsuo, Malka Epel, et al.
Blood|June 10, 2010
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIREynav Klechevsky, Anne-Laure Flamar, Yanying Cao, et al.
JAMA Oncology|July 8, 2021
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for CancerTal Goshen-Lago, Ithai Waldhorn, Roy Holland, et al.
European Journal of Immunology|February 7, 2008
Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d moleculesGalit Denkberg, Victoria S Stronge, Efrat Zahavi, et al.
Nano Letters|May 26, 2022
Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 DiabetesArbel Artzy-Schnirman, Enas Abu-Shah, Rona Chandrawati, et al.
Immunity|June 14, 2008
The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradationAvital Lev, Kazuyo Takeda, Damien Zanker, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell primingJacques Banchereau, Sandra Zurawski, LuAnn Thompson-Snipes, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Cancer Research|April 3, 2004
Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cellsSangKon Oh, Masaki Terabe, C David Pendleton, et al.
Molecular Systems Biology|April 30, 2009
Predicting and controlling the reactivity of immune cell populations against cancerKfir Oved, Eran Eden, Martin Akerman, et al.
Journal of Autoimmunity|October 3, 2012
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell toleranceArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
European Journal of Immunology|September 16, 2004
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragmentsGerhard Held, Mitsutoshi Matsuo, Malka Epel, et al.
Blood|June 10, 2010
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIREynav Klechevsky, Anne-Laure Flamar, Yanying Cao, et al.
JAMA Oncology|July 8, 2021
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for CancerTal Goshen-Lago, Ithai Waldhorn, Roy Holland, et al.
European Journal of Immunology|February 7, 2008
Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d moleculesGalit Denkberg, Victoria S Stronge, Efrat Zahavi, et al.
Nano Letters|May 26, 2022
Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 DiabetesArbel Artzy-Schnirman, Enas Abu-Shah, Rona Chandrawati, et al.
Immunity|June 14, 2008
The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradationAvital Lev, Kazuyo Takeda, Damien Zanker, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell primingJacques Banchereau, Sandra Zurawski, LuAnn Thompson-Snipes, et al.
Pageof 8